Compare Halozyme Therapeutics Inc. Common Stock (HALO) vs Magna International Inc. Common Stock (MGA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Halozyme Therapeutics Inc. Common Stock vs Magna International Inc. Common Stock — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $110.42 (market cap $12.58B), while Magna International Inc. Common Stock trades at $63.99 (market cap $17.04B). The key difference: Magna International Inc. Common Stock is the larger of the two by market cap, and Magna International Inc. Common Stock pays a 3.1% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and Magna International Inc. Common Stock for 1 Days on average.
| HALO | MGA | |
|---|---|---|
Market Cap | $12.58B | $17.04B |
Volume | 2,179,278 | 1,523,784 |
Sector | Health | Consumer Cyclical |
52-Week High | $115.22 | $73.05 |
52-Week Low | $61.63 | $43.54 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $14.49B | $22.08B |
Dividend Yield | — | 3.1% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →About Magna International Inc. Common Stock
Magna International Inc. is a Canada-based automotive supplier that designs, engineers, and manufactures vehicle systems and components, including body and chassis structures, seating, powertrain, and electronics, and provides complete-vehicle engineering and contract assembly, with manufacturing operations in 28 countries.
Read more on MGA →
